Patients with early-stage triple-negative breast cancer (TNBC) and high immune infiltration showed improved disease-free survival (DFS) with adjuvant capecitabine. These “immune-hot” patients had a ...
A supercharged HIV vaccine could offer strong protection with just one injection, a study in mice has indicated. Developed by researchers from the Massachusetts Institute of Technology (MIT) and the ...
Additives like aluminum in vaccines can amp up their effectiveness, creating just the right balance of inflammation to prevent disease. In this illustration, an mRNA vaccine messages cells to make the ...
The Kawasaki Innovation Center for NanoMedicine (iCONM; Director: Kazunori Kataoka; Location: Kawasaki, Japan) have announced with Tokyo Medical and Dental University, and Kyorin University that a ...
In the quest to develop an effective HIV vaccine, scientists from Scripps Research have made a significant leap forward. They found that a two-part delivery strategy can train the immune system to ...
DASL technology was used to quantify mRNA in samples from 1,282 patients enrolled onto the Combination Chemotherapy With or Without Trastuzumab in Treating Women With Breast Cancer (North Central ...
The vaccine employs lipid nanoparticles as delivery vehicles, to transport cancer antigens and powerful super adjuvants to ...
A randomized phase III clinical trial of yoga for chemotherapy-induced peripheral neuropathy treatment. Background: Adjuvant therapy with immune checkpoint inhibitors (ICIs) is approved for melanoma, ...
AUSTIN, Texas--(BUSINESS WIRE)--SynShark and Phylloceuticals have announced the formation of a strategic partnership that is likely to change the way squalene, a critical immunologic adjuvant, is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback